TLPPF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Telix Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 11.5 USD 0.44% Market Closed

Market Cap: $3.8B

T	Telix Pharmaceuticals Ltd OTC:TLPPF	AU
	Anglo American Platinum Ltd F:RPH1	ZA
	Pexip Holding ASA F:4W9	NO
	Essity AB (publ) F:ESWB	SE
	Bosch Ltd NSE:BOSCHLTD	IN
E	EnBW Energie Baden Wuerttemberg AG F:EBK	DE

Profitability Summary

Telix Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

58%

Declining Gross Margin

62% > 48%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

-7% > 4%

Negative Net Margin

-1%

Low 3Y Average Net Margin

Net Margin is Increasing

-13% > -1%

Negative Free Cash Flow Margin

-9%

Negative 3Y Average Free Cash Flow Margin

-1%

Declining Free Cash Flow Margin

1% > -9%

Negative ROE

-2%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.